Related Experiment Videos
Nicholas Muzyczka, PhD [1947-2023]
Kenneth I Berns1, Barry J Byrne2, Terence R Flotte3
1Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, Florida, USA.
Human Gene Therapy
|February 16, 2023
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Meeting report: 2025 muscular dystrophy association summit on 'safety and challenges in gene therapy of neuromuscular diseases'.
Journal of neuromuscular diseases·2026
Sirolimus for the treatment of steroid-refractory hepatotoxicity following AAV gene therapy in patients with Duchenne muscular dystrophy.
Journal of neuromuscular diseases·2026
Gait analysis reveals new outcome measures for monitoring disease progression in individuals with late-onset Pompe disease.
Journal of neuroengineering and rehabilitation·2026
Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.
Therapeutic advances in rare disease·2026
Mapping glycogen accumulation and treatment effect in Pompe disease with saturation transfer MRI.
Translational research : the journal of laboratory and clinical medicine·2026
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
Human gene therapy·2026
Lifestyle-related factors associated with mobility decline in middle-aged adults: A 7-year longitudinal observation of health checkup database.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association·2026
Medicare Advantage and Access to Living Donor Kidney Transplantation among Older Patients Receiving Dialysis.
Journal of the American Society of Nephrology : JASN·2026
Loneliness trajectories surrounding mobility loss: The role of disability duration.
The journals of gerontology. Series B, Psychological sciences and social sciences·2026